What is known about breast cancer in young women?

JW Zhu, P Charkhchi, S Adekunte, MR Akbari - Cancers, 2023 - mdpi.com
Simple Summary Breast cancer is the most common cancer affecting women under 40 years
of age worldwide, with an increasing number of cases diagnosed each year. Despite this …

Next-generation sequencing in oncology: genetic diagnosis, risk prediction and cancer classification

R Kamps, RD Brandão, BJ van den Bosch… - International journal of …, 2017 - mdpi.com
Next-generation sequencing (NGS) technology has expanded in the last decades with
significant improvements in the reliability, sequencing chemistry, pipeline analyses, data …

Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and …

KJ Monahan, N Bradshaw, S Dolwani, B Desouza… - Gut, 2020 - gut.bmj.com
Heritable factors account for approximately 35% of colorectal cancer (CRC) risk, and almost
30% of the population in the UK have a family history of CRC. The quantification of an …

Gene-panel sequencing and the prediction of breast-cancer risk

DF Easton, PDP Pharoah, AC Antoniou… - … England Journal of …, 2015 - Mass Medical Soc
Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk | New England Journal of
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …

NCCN guidelines insights: genetic/familial high-risk assessment: breast and ovarian, version 2.2017

MB Daly, R Pilarski, M Berry, SS Buys… - Journal of the National …, 2017 - jnccn.org
The NCCN Clinical Practice Guidelines in Oncology for Genetic/Familial High-Risk
Assessment: Breast and Ovarian provide recommendations for genetic testing and …

Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer

N Tung, NU Lin, J Kidd, BA Allen, N Singh… - Journal of Clinical …, 2016 - ascopubs.org
Purpose Testing for germline mutations in BRCA1/2 is standard for select patients with
breast cancer to guide clinical management. Next-generation sequencing (NGS) allows …

A study of over 35,000 women with breast cancer tested with a 25‐gene panel of hereditary cancer genes

SS Buys, JF Sandbach, A Gammon, G Patel, J Kidd… - Cancer, 2017 - Wiley Online Library
BACKGROUND As panel testing becomes more common in clinical practice, it is important
to understand the prevalence and trends associated with the pathogenic variants (PVs) …

Endoscopic management of polyposis syndromes: European Society of Gastrointestinal Endoscopy (ESGE) guideline

ME van Leerdam, VH Roos, JE van Hooft… - …, 2019 - thieme-connect.com
ESGE recommends that individuals with hereditary gastrointestinal polyposis syndromes
should be surveilled in dedicated units that provide monitoring of compliance and …

Diagnosis and management of cancer risk in the gastrointestinal hamartomatous polyposis syndromes: recommendations from the US Multi-Society Task Force on …

CR Boland, GE Idos, C Durno, FM Giardiello… - Gastroenterology, 2022 - Elsevier
The gastrointestinal hamartomatous polyposis syndromes are rare, autosomal dominant
disorders associated with an increased risk of benign and malignant intestinal and …

ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes

S Syngal, RE Brand, JM Church… - Official journal of the …, 2015 - journals.lww.com
This guideline presents recommendations for the management of patients with hereditary
gastrointestinal cancer syndromes. The initial assessment is the collection of a family history …